CLEC2D and neoplasm: Based on the role of LLT1 in tumor progression, it has been considered that using LLT1 blocking antibodies could plausibly be a useful strategy to enhance NK cell cytotoxicity, leading to cell lysis, and a novel treatment to prevent tumor metastasis [15,17,26].